Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
FDA approved for patients 2 years and older with obesity due to BBS Help switch on the POWER of the PATHWAY IMCIVREE is the first and only treatment that targets impairment of the hypothalamic MC4R pathway, a root cause of hyperphagia and obesity due to Bardet-Biedl syndrome (BBS)
These alterations preserve approximately 97% sequence homology with native human GLP-1 [18]
Be patient with yourself and stay committed to your healthy eating and lifestyle changes
This should be individualised based on your needs and medical conditionsparticularly if you have kidney disease, where protein intake may need restriction
US$ 24.21
US$ 24.50
US$ 21.07
US$ 29.89
US$ 22.21
